221
Active Trials
69
Phase 1
80
Phase 2
93
Phase 3
13
Therapeutic Areas
Portfolio Concentration: 64% of active trials in Oncology
Oncology
141 active / 420 total
Breast Cancer
23 active
10 Ph3
57 total since 2015
Solid Tumor (Advanced)
22 active
6 Ph3
78 total since 2015
NSCLC
18 active
10 Ph3
51 total since 2015
Non-Hodgkin Lymphoma
17 active
6 Ph3
41 total since 2015
Multiple Myeloma
7 active
15 total since 2015
Hepatocellular Carcinoma
7 active
4 Ph3
13 total since 2015
Colorectal Cancer
6 active
19 total since 2015
Melanoma
4 active
20 total since 2015
Bladder Cancer
4 active
1 Ph3
12 total since 2015
Renal Cell Carcinoma
3 active
8 total since 2015
Esophageal Cancer
3 active
1 Ph3
6 total since 2015
Gastric Cancer
3 active
5 total since 2015
Lung Cancer (General)
3 active
3 Ph3
4 total since 2015
Ovarian Cancer
2 active
7 total since 2015
Prostate Cancer
2 active
6 total since 2015
CLL
2 active
5 total since 2015
Pancreatic Cancer
2 active
4 total since 2015
HER2+ Breast Cancer
2 active
1 Ph3
2 total since 2015
Triple Negative Breast Cancer
1 active
10 total since 2015
SCLC
1 active
1 Ph3
8 total since 2015
Head and Neck Cancer
1 active
5 total since 2015
Cervical Cancer
1 active
4 total since 2015
Hodgkin Lymphoma
1 active
4 total since 2015
Cholangiocarcinoma
1 active
4 total since 2015
Thyroid Cancer
1 active
4 total since 2015
Neuroendocrine Tumors
1 active
3 total since 2015
Brain Tumor
1 active
2 total since 2015
Sarcoma
1 active
2 total since 2015
Endometrial Cancer
1 active
1 total since 2015
ALL
0 active
8 total since 2015
AML
0 active
5 total since 2015
Hematologic Malignancies
0 active
4 total since 2015
Glioblastoma
0 active
1 total since 2015
MDS
0 active
1 total since 2015
Myelofibrosis
0 active
1 total since 2015
CNS
29 active / 83 total
Multiple Sclerosis
17 active
10 Ph3
31 total since 2015
Alzheimer's Disease
6 active
3 Ph3
25 total since 2015
Huntington's Disease
3 active
6 total since 2015
Parkinson's Disease
3 active
1 Ph3
4 total since 2015
Autism Spectrum Disorder
0 active
9 total since 2015
Schizophrenia
0 active
5 total since 2015
ALS
0 active
2 total since 2015
Major Depression
0 active
1 total since 2015
Immunology
28 active / 89 total
Ankylosing Spondylitis
6 active
4 Ph3
25 total since 2015
Ulcerative Colitis
6 active
3 Ph3
13 total since 2015
Rheumatoid Arthritis
5 active
2 Ph3
27 total since 2015
Lupus
5 active
2 Ph3
9 total since 2015
Crohn's Disease
4 active
3 Ph3
9 total since 2015
Atopic Dermatitis
2 active
5 total since 2015
Psoriasis
0 active
1 total since 2015
Rare Disease
15 active / 30 total
Metabolic
15 active / 28 total
Ophthalmology
10 active / 22 total
Respiratory
5 active / 29 total
Cardiovascular
2 active / 18 total
Infectious Disease
1 active / 22 total
Urology
1 active / 8 total
Renal
1 active / 1 total
Endocrine
0 active / 1 total
Gastrointestinal
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)